Jong Oh Kim

Jong Oh Kim

Yeungnam University
Verified email at yu.ac.kr
Cited by 27434
nanoparticle nanomedicine chemotherapy immunotherapy LNP
costanza emanueli

costanza emanueli

Imperial College London
Verified email at imperial.ac.uk
Cited by 18777
cardiovascular RNA therapeutics extracellular vesicles LNP bioengineering
Christopher J Cheng

Christopher J Cheng

Verve Therapeutics
Verified email at vervetx.com
Cited by 4936
Nucleic acid therapeutics mRNA gene editing LNP RNA process development
Xingguo Cheng

Xingguo Cheng

Immorna Biotherapuetics
Verified email at immornabio.com
Cited by 4201
LNP Formulation Manufacturing Preclinical IND
oula penate medina

oula penate medina

Lonza Geleen
Verified email at Lonza.com
Cited by 4071
LNP nanotechnology lipids peptides RNA
Jonathan D Finn

Jonathan D Finn

Verified email at tome.bio
Cited by 4008
gene therapy LNP exosome AAV CRISPR
Hongwei Zhang, Ph.D.

Hongwei Zhang, Ph.D.

Associate Professor of Pharmaceutics, School of Pharmacy-Boston, MCPHS University
Verified email at mcphs.edu
Cited by 2715
Gene therapy AAV LNP drug delivery
Chunhua Yang

Chunhua Yang

IBMS, GSU
Verified email at gatech.edu
Cited by 2649
Integrated Drug Discovery Drug Discovery–DDS Co-Development LNP Oral Drug Delivery
Walter R Strapps

Walter R Strapps

CSO at Liberate Bio
Verified email at liberatebio.com
Cited by 2625
genetics gene editing oligonucleotides LNP delivery
Alireza Nomani, PhD

Alireza Nomani, PhD

Regeneron Pharmaceuticals
Verified email at regeneron.com
Cited by 1698
LNP Antibody-Drug Conjugates mAb Formulation qMRI
1 - 10